Synthetic biology is crucial for engineering more potent BCMA-targeting CAR T cells, nevertheless, maintaining tumor-associated-BCMA expression and preventing antigen loss, is required for their execution of potency. The gene discussed is TNFRSF17; the disease is neoplasm.